EQUILLIUM, INC. Amortization of Debt Issuance Costs and Discounts
EQUILLIUM, INC. (EQ) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2025-03-27
- EQUILLIUM, INC. amortization of debt issuance costs and discounts for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- EQUILLIUM, INC. amortization of debt issuance costs and discounts for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- EQUILLIUM, INC. amortization of debt issuance costs and discounts for the quarter ending 2023-06-30 was $150.00K, a 188.46% increase year-over-year.
- EQUILLIUM, INC. amortization of debt issuance costs and discounts for the quarter ending 2023-03-31 was $30.00K, a 37.50% decline year-over-year.
- EQUILLIUM, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- EQUILLIUM, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $180.00K, a 11.33% decline from fiscal 2022.
- EQUILLIUM, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $203.00K, a 14.35% decline from fiscal 2021.
- EQUILLIUM, INC. amortization of debt issuance costs and discounts for fiscal 2021 was $237.00K, a 8.85% decline from fiscal 2020.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-27 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $150.00K derived: sum of 3 quarters · filed 2025-03-27 | $180.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $150.00K derived: sum of 2 quarters · filed 2024-11-13 | $180.00K 10-Q · filed 2024-11-13 | $231.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $180.00K 10-Q · filed 2024-08-08 | $231.00K derived: sum of 3 quarters · filed 2024-08-08 | $283.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $30.00K 10-Q · filed 2024-05-09 | $81.00K derived: sum of 2 quarters · filed 2024-05-09 | $133.00K derived: sum of 3 quarters · filed 2024-05-09 | $185.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $103.00K derived: sum of 2 quarters · filed 2024-03-25 | $155.00K derived: sum of 3 quarters · filed 2024-03-25 | $203.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $104.00K derived: sum of 2 quarters · filed 2023-11-08 | $152.00K 10-Q · filed 2023-11-08 | $207.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $100.00K 10-Q · filed 2023-08-09 | $155.00K derived: sum of 3 quarters · filed 2023-08-09 | $211.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $48.00K 10-Q · filed 2023-05-11 | $103.00K derived: sum of 2 quarters · filed 2023-05-11 | $159.00K derived: sum of 3 quarters · filed 2023-05-11 | $221.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $111.00K derived: sum of 2 quarters · filed 2023-03-23 | $173.00K derived: sum of 3 quarters · filed 2023-03-23 | $237.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $118.00K derived: sum of 2 quarters · filed 2022-11-14 | $182.00K 10-Q · filed 2022-11-14 | $247.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $126.00K 10-Q · filed 2022-08-15 | $191.00K derived: sum of 3 quarters · filed 2022-08-15 | $256.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $64.00K 10-Q · filed 2022-05-12 | $129.00K derived: sum of 2 quarters · filed 2022-05-12 | $194.00K derived: sum of 3 quarters · filed 2022-05-12 | $259.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $130.00K derived: sum of 2 quarters · filed 2022-03-23 | $195.00K derived: sum of 3 quarters · filed 2022-03-23 | $260.00K 10-K · filed 2022-03-23 |
| 2020-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $130.00K derived: sum of 2 quarters · filed 2021-11-10 | $195.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $130.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $65.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $65.00K 10-K · filed 2021-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |